Baxter's $4B bid for Gambro likely to win EU clearance, sources say

07/11/2013 | Reuters

Baxter International's offer to acquire Gambro for $4 billion could be cleared by the European Commission in its decision expected by July 22, according to people familiar with the issue. The news comes after Baxter vowed to divest its global continuous renal replacement therapy unit to allay competition fears.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
Nationwide, SL_Nationwide
Finance Manager - ENT
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA